全文获取类型
收费全文 | 50565篇 |
免费 | 4020篇 |
国内免费 | 108篇 |
专业分类
耳鼻咽喉 | 547篇 |
儿科学 | 1867篇 |
妇产科学 | 1327篇 |
基础医学 | 6334篇 |
口腔科学 | 488篇 |
临床医学 | 6507篇 |
内科学 | 9107篇 |
皮肤病学 | 1012篇 |
神经病学 | 5218篇 |
特种医学 | 1031篇 |
外科学 | 5306篇 |
综合类 | 415篇 |
现状与发展 | 1篇 |
一般理论 | 88篇 |
预防医学 | 7094篇 |
眼科学 | 851篇 |
药学 | 3535篇 |
中国医学 | 60篇 |
肿瘤学 | 3905篇 |
出版年
2024年 | 48篇 |
2023年 | 478篇 |
2022年 | 702篇 |
2021年 | 1832篇 |
2020年 | 1121篇 |
2019年 | 1825篇 |
2018年 | 1929篇 |
2017年 | 1491篇 |
2016年 | 1568篇 |
2015年 | 1664篇 |
2014年 | 2328篇 |
2013年 | 3056篇 |
2012年 | 4566篇 |
2011年 | 4493篇 |
2010年 | 2452篇 |
2009年 | 2036篇 |
2008年 | 3527篇 |
2007年 | 3506篇 |
2006年 | 3255篇 |
2005年 | 3054篇 |
2004年 | 2638篇 |
2003年 | 2218篇 |
2002年 | 1928篇 |
2001年 | 286篇 |
2000年 | 189篇 |
1999年 | 267篇 |
1998年 | 321篇 |
1997年 | 233篇 |
1996年 | 196篇 |
1995年 | 175篇 |
1994年 | 131篇 |
1993年 | 106篇 |
1992年 | 93篇 |
1991年 | 83篇 |
1990年 | 89篇 |
1989年 | 76篇 |
1988年 | 56篇 |
1987年 | 51篇 |
1986年 | 54篇 |
1985年 | 55篇 |
1984年 | 63篇 |
1983年 | 48篇 |
1982年 | 37篇 |
1981年 | 27篇 |
1980年 | 25篇 |
1979年 | 32篇 |
1978年 | 34篇 |
1976年 | 27篇 |
1975年 | 27篇 |
1972年 | 26篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
992.
993.
Evaluation of the likelihood of a selective CHK1 inhibitor (LY2603618) to inhibit CYP2D6 with desipramine as a probe substrate in cancer patients
下载免费PDF全文
![点击此处可从《Biopharmaceutics & drug disposition》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Scott M. Hynes Enaksha Wickremsinhe Wei Zhang Rodney Decker Jennifer Ott Jason Chandler Malcolm Mitchell 《Biopharmaceutics & drug disposition》2015,36(1):49-63
LY2603618 is a selective inhibitor of deoxyribonucleic acid damage checkpoint kinase 1 (CHK1) and has been in development for the enhancement of chemotherapeutic agents. The study described was to assess the potential interaction between LY2603618 and cytochrome P450 isoform 2D6 (CYP2D6) substrate desipramine in patients with cancer. Before clinical investigation, in silico simulations (using Simcyp®) were conducted. An open‐label, two‐period, fixed‐sequence study was planned in 30 patients with advanced or metastatic cancers, in which a 50 mg oral dose of desipramine was administered alone and in combination with 275 mg of LY2603618 (i.v. infusion). An interim analysis was planned after 15 patients completed both periods. Ratios of geometric least squares means (LSMs) of primary pharmacokinetic (PK) parameters and 90% repeated confidence intervals (RCIs) between desipramine plus LY2603618 and desipramine alone were calculated. Lack of an interaction was declared if the 90% RCI fell between 0.8 and 1.25. The LSM ratios (90% RCI) for areas under the plasma concentration–time curve from time zero to tlast (AUC[0‐tlast]) and to infinity (AUC[0‐∞]) and maximum plasma concentration (Cmax) were 1.14 (1.04, 1.25), 1.09 (0.99, 1.21) and 1.16 (1.05, 1.29). In silico simulations were predictive of clinical results. Single doses of 275 mg LY2603618 administered with 50 mg desipramine were generally well tolerated. In conclusion, no clinically significant interaction was observed between LY2603618 and desipramine in patients with cancer. In silico predictions of clinical results demonstrated that mechanistic and physiologically based PK approaches may inform clinical study design in cancer patients. Copyright © 2014 John Wiley & Sons, Ltd. 相似文献
994.
Jennifer Barber Tricia M McKeever Sarah E McDowell Jennifer A Clayton Robin E Ferner Richard D Gordon Michael Stowasser Kevin M O'Shaughnessy Ian P Hall Mark Glover 《British journal of clinical pharmacology》2015,79(4):566-577
AIMS
Hyponatraemia is one of the major adverse effects of thiazide and thiazide-like diuretics and the leading cause of drug-induced hyponatraemia requiring hospital admission. We sought to review and analyze all published cases of this important condition.METHODS
Ovid Medline, Embase, Web of Science and PubMed electronic databases were searched to identify all relevant articles published before October 2013. A proportions meta-analysis was undertaken.RESULTS
One hundred and two articles were identified of which 49 were single patient case reports. Meta-analysis showed that mean age was 75 (95% CI 73, 77) years, 79% were women (95% CI 74, 82) and mean body mass index was 25 (95% CI 20, 30) kg m−2. Presentation with thiazide-induced hyponatraemia occurred a mean of 19 (95% CI 8, 30) days after starting treatment, with mean trough serum sodium concentration of 116 (95% CI 113, 120) mm and serum potassium of 3.3 (95% CI 3.0, 3.5) mm. Mean urinary sodium concentration was 64 mm (95% CI 47, 81). The most frequently reported drugs were hydrochlorothiazide, indapamide and bendroflumethiazide.CONCLUSIONS
Patients with thiazide-induced hyponatraemia were characterized by advanced age, female gender, inappropriate saliuresis and mild hypokalaemia. Low BMI was not found to be a significant risk factor, despite previous suggestions. The time from thiazide initiation to presentation with hyponatraemia suggests that the recommended practice of performing a single investigation of serum biochemistry 7–14 days after thiazide initiation may be insufficient or suboptimal. Further larger and more systematic studies of thiazide-induced hyponatraemia are required. 相似文献995.
996.
Bego?a Heras Martin J Scanlon Jennifer L Martin 《British journal of clinical pharmacology》2015,79(2):208-215
New antibacterials need new approaches to overcome the problem of rapid antibiotic resistance. Here we review the development of potential new antibacterial drugs that do not kill bacteria or inhibit their growth, but combat disease instead by targeting bacterial virulence. 相似文献
997.
M. Allison Arwady Luke Bawo Jennifer C. Hunter Moses Massaquoi Almea Matanock Bernice Dahn Patrick Ayscue Tolbert Nyenswah Joseph D. Forrester Lisa E. Hensley Benjamin Monroe Randal J. Schoepp Tai-Ho Chen Kurt E. Schaecher Thomas George Edward Rouse Ilana J. Schafer Satish K. Pillai Kevin M. De Cock 《Emerging infectious diseases》2015,21(4):578-584
Over the span of a few weeks during July and August 2014, events in West Africa changed perceptions of Ebola virus disease (EVD) from an exotic tropical disease to a priority for global health security. We describe observations during that time of a field team from the Centers for Disease Control and Prevention and personnel of the Liberian Ministry of Health and Social Welfare. We outline the early epidemiology of EVD within Liberia, including the practical limitations on surveillance and the effect on the country’s health care system, such as infections among health care workers. During this time, priorities included strengthening EVD surveillance; establishing safe settings for EVD patient care (and considering alternative isolation and care models when Ebola Treatment Units were overwhelmed); improving infection control practices; establishing an incident management system; and working with Liberian airport authorities to implement EVD screening of departing passengers. 相似文献
998.
999.
1000.
Megan A. Campbell Jennifer Hunt David Walker Rodger Williams 《Australian and New Zealand journal of public health》2015,39(1):21-25
Objectives: Aboriginal people continue to experience a disproportionately heavy burden of oral disease. A range of oral health services may be available to Aboriginal communities, including those provided by Aboriginal Community Controlled Health Services (ACCHSs). This study explored the oral health care experiences and activities of ACCHSs to inform policy and program decision making. Methods: Mixed methods, including an online survey and semi‐structured interviews with senior ACCHS staff, were used. Areas of inquiry included perceived community need for oral health care, oral health care models, accessibility of other oral health services and barriers to providing oral health care. Twenty‐nine NSW ACCHSs participated in the study. Results: The activities of NSW ACCHSs in oral health care are diverse and reflect the localised approaches they take to delivering primary health care. ACCHSs commonly face barriers in delivering oral health care, as do Aboriginal communities in accessing other oral health services. Conclusion: NSW ACCHSs are important but under‐acknowledged providers of a range of oral health services to Aboriginal communities and are well placed to provide this care as part of their comprehensive primary health care model. Implications: ACCHS roles in improving Aboriginal oral health would be strengthened by greater acknowledgement of their contributions and expertise and the development of transparent, long‐term funding policies that respond to community need. 相似文献